Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2026)

Phibro Animal Health's Long-Term Investments history runs 8 years deep, the most recent figure standing at $991000.0 for Q1 2026.

• On a quarterly basis, Long-Term Investments fell 84.54% year-over-year to $991000.0 in Q1 2026; TTM through Mar 2026 was $991000.0, a 84.54% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, down 18.45% from the prior year.
• Long-Term Investments rose to $991000.0 in Q1 2026 per PAHC's latest filing, from $367000.0 in the prior quarter.
• Across five years, Long-Term Investments topped out at $13.4 million in Q4 2022 and bottomed at $367000.0 in Q4 2025.
• The 5-year median for Long-Term Investments is $6.1 million (2023), against an average of $5.8 million.
• Across the five-year window, Long-Term Investments jumped 183.38% in 2022 and sank 90.1% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $13.4 million in 2022, then plunged by 67.22% to $4.4 million in 2023, then declined by 15.38% to $3.7 million in 2024, then tumbled by 90.1% to $367000.0 in 2025, then surged by 170.03% to $991000.0 in 2026.
• Per Business Quant, the three latest PAHC Long-Term Investments figures stand at $991000.0 (Q1 2026), $367000.0 (Q4 2025), and $8.4 million (Q3 2025).